Initiating Oseltamivir in Adults Hospitalized With Influenza -- a Study on the Impact of Virological Clearance and Clinical Recovery for Higher-dose Treatment Started Within 96 Hours.

Trial Profile

Initiating Oseltamivir in Adults Hospitalized With Influenza -- a Study on the Impact of Virological Clearance and Clinical Recovery for Higher-dose Treatment Started Within 96 Hours.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jul 2012

At a glance

  • Drugs Oseltamivir (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jul 2012 Actual end date (June 2012) added as reported by ClinicalTrials.gov.
    • 19 Jul 2012 Actual initiation date (January 2010) added as reported by ClinicalTrials.gov.
    • 01 Jun 2012 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top